Business Description
Sareum Holdings PLC
ISIN : GB00BMC3RJ87
Description
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.76 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -29.1 | |||||
| 3-Year EPS without NRI Growth Rate | -22.2 | |||||
| 3-Year FCF Growth Rate | -26 | |||||
| 3-Year Book Growth Rate | -21.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.06 | |||||
| 9-Day RSI | 21.58 | |||||
| 14-Day RSI | 25.96 | |||||
| 6-1 Month Momentum % | -23.19 | |||||
| 12-1 Month Momentum % | -53.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.22 | |||||
| Quick Ratio | 4.22 | |||||
| Cash Ratio | 2.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.4 | |||||
| Shareholder Yield % | -15.56 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -278.5 | |||||
| ROA % | -151.91 | |||||
| ROIC % | -488.63 | |||||
| 3-Year ROIIC % | -325.66 | |||||
| ROC (Joel Greenblatt) % | -844.95 | |||||
| ROCE % | -289.19 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 11.25 | |||||
| Price-to-Tangible-Book | 11.25 | |||||
| EV-to-EBIT | -5.83 | |||||
| EV-to-EBITDA | -5.83 | |||||
| EV-to-Forward-EBITDA | -13.5 | |||||
| EV-to-Forward-Revenue | 429.05 | |||||
| EV-to-FCF | -6.8 | |||||
| Price-to-Net-Current-Asset-Value | 11.25 | |||||
| Price-to-Net-Cash | 22.5 | |||||
| Earnings Yield (Greenblatt) % | -17.15 | |||||
| FCF Yield % | -13.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sareum Holdings PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | |||
| EPS (TTM) (£) | -0.042 | ||
| Beta | 0.55 | ||
| Volatility % | 178.27 | ||
| 14-Day RSI | 25.96 | ||
| 14-Day ATR (£) | 0.016815 | ||
| 20-Day SMA (£) | 0.25175 | ||
| 12-1 Month Momentum % | -53.91 | ||
| 52-Week Range (£) | 0.1 - 0.65 | ||
| Shares Outstanding (Mil) | 124.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sareum Holdings PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sareum Holdings PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sareum Holdings PLC Frequently Asked Questions
What is Sareum Holdings PLC(LSE:SAR)'s stock price today?
The current price of LSE:SAR is £0.23. The 52 week high of LSE:SAR is £0.65 and 52 week low is £0.10.
When is next earnings date of Sareum Holdings PLC(LSE:SAR)?
The next earnings date of Sareum Holdings PLC(LSE:SAR) is .
Does Sareum Holdings PLC(LSE:SAR) pay dividends? If so, how much?
Sareum Holdings PLC(LSE:SAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers